For long term investors, improvement in profitability and outperformance against the industry can be important characteristics in a stock. In this article, I will take a look at Infomedia Ltd’s ...
How Did IFM’s Recent Performance Stack Up Against Its Past? IFM’s trailing twelve-month earnings (from 30 June 2018) of AU$13m has increased by 7.9% compared to the previous year. Furthermore, this ...
Just two weeks after hauling in a $31 million series A funding round to form a new subsidiary, Boston-based IFM Therapeutics is laying out a case for the unit’s primary drug target: a signaling ...
When Infomedia Ltd (ASX:IFM) released its most recent earnings update (30 June 2018), I compared it against two factor: its historical earnings track record, and the performance of its industry peers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback